Return to homepagePandemic Pact

PPP compute: Pandemic pharmacology platform for model-driven therapy optimization

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.07101E+13

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2024
    2026

  • Known Financial Commitments (USD)

    $0

  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)

  • Principal Investigator

    dr. JGC van Hasselt

  • Research Location

    Netherlands

  • Lead Research Institution

    Universiteit Leiden

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

During a pandemic, a rapid evaluation of possible medicines to be able to treat infected patients is necessary. During the COVID-19 Pandemie, pre-clinical studies were conducted worldwide to identify possible medicines with activity against SARS-COV-2. In many cases, no clinical effect has been found for a large number of medicines. The cause for this may be in a lack of translation of experimental findings into people and/or by testing unsuitable doses.